TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 60 filers reported holding TAYSHA GENE THERAPIES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $12 | -45.5% | 18,077 | -33.9% | 0.00% | -50.0% |
| Q1 2023 | $22 | -94.7% | 27,338 | -85.1% | 0.00% | -96.2% |
| Q4 2022 | $416 | -99.9% | 183,857 | -22.1% | 0.05% | -13.3% |
| Q3 2022 | $456,000 | -34.3% | 236,120 | +26.6% | 0.06% | -42.3% |
| Q2 2022 | $694,000 | -9.2% | 186,480 | +59.2% | 0.10% | +1.0% |
| Q1 2022 | $764,000 | +60.5% | 117,109 | +186.4% | 0.10% | +71.7% |
| Q4 2021 | $476,000 | +6.2% | 40,885 | +104.4% | 0.06% | -20.0% |
| Q3 2020 | $448,000 | – | 20,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 1,391,190 | $29,493,000 | 22.62% |
| Octagon Capital Advisors LP | 320,440 | $6,793,000 | 1.41% |
| Artal Group S.A. | 1,040,882 | $22,067,000 | 0.45% |
| Alphabet Inc. | 640,882 | $13,587,000 | 0.28% |
| Nantahala Capital Management | 432,072 | $9,160,000 | 0.26% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 500,000 | $10,600,000 | 0.22% |
| TimesSquare Capital Management, LLC | 683,400 | $14,488,000 | 0.12% |
| Perceptive Advisors | 640,880 | $13,586,000 | 0.09% |
| Virtus ETF Advisers LLC | 8,697 | $184,000 | 0.08% |
| Granite Point Capital Management, L.P. | 50,000 | $1,060,000 | 0.04% |